VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
+10.73%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$188M
AUM Growth
+$30.7M
(+19%)
Cap. Flow
+$19.9M
Cap. Flow
% of AUM
10.59%
Top 10 Holdings %
Top 10 Hldgs %
6.1%
Holding
495
New
69
Increased
189
Reduced
162
Closed
73
Top Buys
| 1 |
Palantir
PLTR
|
$1.01M |
| 2 |
BlackRock TCP Capital
TCPC
|
$1M |
| 3 |
Host Hotels & Resorts
HST
|
$993K |
| 4 |
DFS
Discover Financial Services
DFS
|
$989K |
| 5 |
Public Storage
PSA
|
$931K |
Top Sells
| 1 |
Burlington
BURL
|
$962K |
| 2 |
Prologis
PLD
|
$773K |
| 3 |
Booking.com
BKNG
|
$734K |
| 4 |
Eaton
ETN
|
$720K |
| 5 |
TE Connectivity
TEL
|
$708K |
Sector Composition
| 1 | Healthcare | 21.52% |
| 2 | Financials | 20.16% |
| 3 | Technology | 16.46% |
| 4 | Industrials | 8.76% |
| 5 | Energy | 7.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Harmony Biosciences
HRMY
$2.07B
| $379K | 0.2% |
11,280
+1,623
| +17% | +$54.5K |
|
|
DCPH
202
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $379K | 0.2% |
24,069
+3,463
| +17% | +$54.5K |
|
203
Oxford Square Capital
OXSQ
$172M
| $373K | 0.2% |
117,596
+27,120
| +30% | +$86K |
|
204
Invesco Quality Municipal Securities
IQI
$507M
| $372K | 0.2% |
38,472
+6,604
| +21% | +$63.9K |
|
|
BCIC
205
BCP Investment Corporation Common Stock
BCIC
$160M
| $372K | 0.2% |
19,589
+4,014
| +26% | +$76.2K |
|
206
Viking Therapeutics
VKTX
$3.03B
| $370K | 0.2% |
4,511
-306
| -6% | -$25.1K |
|
207
Roivant Sciences
ROIV
$8.82B
| $361K | 0.19% |
34,233
+4,925
| +17% | +$51.9K |
|
208
Amicus Therapeutics
FOLD
$2.46B
| $361K | 0.19% |
30,604
+4,403
| +17% | +$51.9K |
|
209
Insmed
INSM
$30.7B
| $358K | 0.19% |
13,193
+1,898
| +17% | +$51.5K |
|
210
Monroe Capital Corp
MRCC
$164M
| $358K | 0.19% |
49,660
+12,700
| +34% | +$91.4K |
|
211
Legend Biotech
LEGN
$6.66B
| $348K | 0.19% |
6,207
+893
| +17% | +$50.1K |
|
212
United Therapeutics
UTHR
$18.1B
| $345K | 0.18% |
1,500
+216
| +17% | +$49.6K |
|
213
Gilead Sciences
GILD
$143B
| $341K | 0.18% |
4,659
+670
| +17% | +$49.1K |
|
214
BioMarin Pharmaceuticals
BMRN
$11.1B
| $341K | 0.18% |
3,904
+562
| +17% | +$49.1K |
|
215
Travere Therapeutics
TVTX
$1.93B
| $340K | 0.18% |
44,150
+6,352
| +17% | +$49K |
|
216
Incyte
INCY
$16.9B
| $340K | 0.18% |
5,969
+859
| +17% | +$48.9K |
|
217
BioNTech
BNTX
$27B
| $338K | 0.18% |
3,665
+527
| +17% | +$48.6K |
|
|
SAGE
218
DELISTED
Sage Therapeutics
SAGE
| $337K | 0.18% |
17,965
+2,585
| +17% | +$48.4K |
|
219
Ionis Pharmaceuticals
IONS
$9.76B
| $332K | 0.18% |
7,648
+1,100
| +17% | +$47.7K |
|
220
BridgeBio Pharma
BBIO
$10.2B
| $328K | 0.17% |
10,611
+1,527
| +17% | +$47.2K |
|
221
Biogen
BIIB
$20.6B
| $320K | 0.17% |
1,486
+214
| +17% | +$46.1K |
|
|
ONC
222
BeOne Medicines Ltd. American Depositary Shares
ONC
$37.6B
| $318K | 0.17% |
2,031
+292
| +17% | +$45.7K |
|
223
OFS Capital
OFS
$117M
| $315K | 0.17% |
31,724
+6,377
| +25% | +$63.3K |
|
224
Theravance Biopharma
TBPH
$703M
| $310K | 0.16% |
34,607
+4,979
| +17% | +$44.7K |
|
225
Alnylam Pharmaceuticals
ALNY
$59.2B
| $305K | 0.16% |
2,043
+294
| +17% | +$43.9K |
|